Today's Pick: One frugal biotech

Johnny Stine: eBay and Biotech

Got no money but want to be an entrepreneur?

A story in the October 2009 issue of The Scientist might offer up some inspiration.  “Startup on the cheap” tells the story of North Coast Biologics, a biotech start-up created with just $ 40,000USD and a whole lot of sweat equity (of the ‘renovate and build out your own lab’ kind).  Using eBay and Craigslist to equip his lab, founder Johnny Stines is now producing monoclonal antibodies for three clients.

To read the article and view a video of Stines in his lab, see: http://www.the-scientist.com/2009/10/1/22/1/

Related Blogs

 

Today’s VCs tell you the secrets of a successful pitch
At last week’s Entrepreneurship 101 lecture on raising money, leading venture capitalists divulged the secrets of successfully pitching to an investor. The secret is in the relationship. The pa

Entrepreneurship 101: Debt vs equity
Entrepreneurship 101 This week’s Entrepreneurship 101 session focussed on different types of entrepreneurship and about the resources required in each case — particularly cash needs. We

Entrepreneurship 101 – Science and business do mix: success story
Entrepreneurship 101 This week’s Entrepreneurship 101 featured Dr. Michael May, founder of Rimon Therapeutics, and his success story. Michael founded Rimon based, in part, on his thesis work f

BioEntrepreneurship: The business of biotech
BioEntrepreneurship At last night’s opening BioEntrepreneurship seminar, Dr Lynne Zydowsky, a seasoned industry consultant from California, gave us an in-depth view of the main drivers of toda

Securing funds in the biotech industry: Raymond King from the TSX
Last week, I spoke with Raymond King, the Senior Manager for Global Diversified Industries, Listings Business Development at the Toronto Stock Exchange (TSX) and TSX Venture Exchange.  King will be

BIO 2010: Impressions
Just got back from the 2010 BIO International Convention in Chicago – the Superbowl of the biotech industry. Last year’s BIO was a decidedly gloomy affair as investment dropped to levels

Tags: biotechnology, entrepreneurship, finance, product development